A2349C Regulatory Approval Plan for Glucura by Cura Pharmaceuticals | Case Study, AY2024 Term 4

Case Study:

Singapore-based company, Cura Pharmaceuticals, has local research, manufacturing, and warehousing facilities. They recently completed clinical trials for their new anti-diabetic drug, the first in its pharmacological class, and have decided to name the product Glucura.

As the Regulatory Affairs Manager at Cura Pharmaceuticals, your task is to navigate the Health Sciences Authority (HSA)’s licensing processes to obtain approval for the manufacture, distribution, and sale of Glucura in Singapore. You are responsible for ensuring that Glucura complies with all the regulatory requirements and to successfully obtain all the required registration and licenses for this product.

You are to prepare a set of no more than 10 presentation slides for the purpose of presenting your plan to obtain the necessary approvals for Glucura to the management of Cura Pharmaceuticals.

Guidelines for Preparing the Plan

• Identify the type of product that Glucura is, in legislative terms.
• Identify which legislation or guidelines that Glucura is regulated under.
• Identify the required registration and/or licensing for Glucura, taking into account all the relevant requirements, guidelines, and/or exemptions for each of the procedures.
• Include any other factors that Cura Pharmaceuticals need to consider while obtaining the required registration and licenses for Glucura.
• Justify your points wherever necessary.

Include at least 2 references for your presentation.

The post A2349C Regulatory Approval Plan for Glucura by Cura Pharmaceuticals | Case Study, AY2024 Term 4 appeared first on Singapore Assignment Help.